Table 8. Case fatality analysis of TBRF (n = 17 studies).
| Patient group | Number of fatal cases (%) | Number of documented fatal cases among cases with documented antimicrobial treatment (N = 629) | Number of documented fatal cases among cases with unknown antimicrobial treatment status (N = 816) | Number of documented fatal cases among documented untreated cases (N = 9) |
|---|---|---|---|---|
| All cases of TBRF not infected during pregnancy and not infected in the fetal or peripartal period (N = 992) | 43 (4.3%) | 38 | 5 | 0 |
| Pregnant women (N = 231) | 11 (4.8%) | 0 | 11 | 0 |
| Fetuses and neonates (N = 231) | 0 | |||
| Intrauterine death | 11 (4.8%) | 2 | 9 | 0 |
| Postpartal death | 30 (13.0%) | 12 | 18 | 0 |
| Total | 95 (6.5%) | 52 | 43 | 0 |
CFR, case fatality rate.